title: IL-1, quo vadis?
authors.affiliation: Institute of Innate Immunity, University Hospitals Bonn, Bonn, Germany.
authors.forename: Alena
authors.initials: A
authors.lastname: Grebe
authors.forename: Eicke
authors.initials: E
authors.lastname: Latz
mesh_terms: D000818:Animals; D001011:Aorta / Q000276:immunology*; D001018:Aortic Diseases / Q000276:immunology*; D001057:Apolipoproteins E / Q000172:deficiency*; D050197:Atherosclerosis / Q000276:immunology*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D007375:Interleukin-1 / Q000378:metabolism*; D008297:Male; D053573:Receptors, Interleukin-1 Type I / Q000378:metabolism*
chemical_list: D001057:Apolipoproteins E; D018836:Inflammation Mediators; D007375:Interleukin-1; D053573:Receptors, Interleukin-1 Type I